Haleon plc Form 6-K Summary
Business context and reporting period
Haleon plc, a foreign private issuer, furnished this Form 6-K for the month of March 2024. The report was signed and furnished on March 18, 2024. It does not contain operating or quarterly financial results.
Key financial metrics
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.
Material changes and transaction information
The filing incorporates Exhibit 99.1, a share repurchase deed between Haleon plc and Pfizer Inc. dated September 11, 2023. The provided filing text does not describe the deed’s consideration, number of shares, completion status, or other economic terms.
Guidance, outlook, risks, and unusual items
No guidance, outlook, management commentary, risk factors, contingencies, or unusual operating items are provided in the filing text.
Investor verification points
- Review Exhibit 99.1 for the terms and status of the share repurchase deed with Pfizer.
- Verify whether subsequent filings provide the transaction value, share count, settlement details, or ownership effects.
- Use Haleon’s annual report or other earnings filings for financial performance, liquidity, leverage, and outlook information.